Home/Pipeline/Autism Biomarker Services

Autism Biomarker Services

Autism

Service OfferingActive

Key Facts

Indication

Autism

Phase

Service Offering

Status

Active

Company

The Siesta Group

About The Siesta Group

The Siesta Group is a Vienna-based, neuroscience-focused service provider that empowers CNS drug development through advanced analysis of EEG, sleep, and activity data. Leveraging over 20 years of experience, proprietary AI-powered analysis tools, and a strong scientific network, the company helps sponsors identify biomarkers and endpoints for conditions ranging from sleep disorders to neurodegenerative diseases. It operates as a trusted partner to over 30 leading sponsors and CROs, offering a full suite of clinical trial services from feasibility to data visualization, all while maintaining rigorous compliance standards.

View full company profile

Therapeutic Areas

Sleep Disorders Sleep Apnea Neurodegenerative Diseases Mood Disorders Schizophrenia Autism Anxiety Disorders

Other Autism Drugs

Drug	Company	Phase	Status
Autism Tablet	OFD Biopharma	Phase II	Active
UCT-MSC + Biomaterials	Vitti Labs	Phase 2	Active
UC-Blood Biomolecules	Vitti Labs	Phase 2	Active
Arfolitixorin	Isofol Medical	Pre-clinical / Discovery	Active
StroMel™ (Planned)	Akan Biosciences	Planned	Active